Carla Grandori

Carla Grandori is a Research Associate Professor at UW where she serves as Director at the Quellos High Throughput Screening (HTS) Core. Carla also leads a laboratory in the Fred Hutchinson Cancer Research Center’s Human Biology Division, where she focuses on identifying therapeutic targets for MYC-driven cancers, in particular neuroblastoma and ovarian cancers. As a cancer molecular and cellular biologist, she has been a pioneer in the application of genomic technologies and high throughput screening to identify new targets for cancer therapy. Carla trained as an M.D. but later decided to pursue a career in science to ultimately contribute to novel therapeutics. In 2006, Carla joined Rosetta Inpharmatics, a subsidy of Merck to exploit her expertise toward identifying new therapeutic cancer targets utilizing high throughput technology. The results of Carla’s research lead to several publications in major journals as well as inventions. Carla’s plan for the future is to foster the rapid discovery of new cancer therapeutics through new initiatives as well as through collaborations with the pharmaceutical industry.